New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 13, 2014
04:55 EDTCGIX, CGIX, CGIX, HART, HART, HART, NURO, NURO, NURO, CANF, CANF, CANF, AMBS, AMBS, AMBS, AGEN, AGEN, AGEN, AVXL, AVXL, AVXL, SYN, SYN, SYN, CEMI, CEMI, CEMI, SRNE, SRNE, SRNE, OXBT, OXBT, OXBTOneMedPlace to hold a forum
7th Annual OneMedForum SF 2014 is being held in San Francisco on January 13-15.
News For CGIX;SRNE;CEMI;SYN;AVXL;AGEN;AMBS;CANF;NURO;HART;OXBT From The Last 14 Days
Check below for free stories on CGIX;SRNE;CEMI;SYN;AVXL;AGEN;AMBS;CANF;NURO;HART;OXBT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 16, 2014
09:31 EDTHARTHarvard Apparatus names Saverio La Francesca as Chief Medical Officer
Subscribe for More Information
April 10, 2014
09:00 EDTHARTHarvard Apparatus rises 10.6%
Subscribe for More Information
08:32 EDTHARTHarvard Apparatus initiated with a Buy at Summer Street
Subscribe for More Information
April 8, 2014
14:08 EDTCANFCan-Fite BioPharma files to sell 3.05M ordinary shares for holders
Represents 1.52M American Depositary Shares.
12:00 EDTSRNESorrento Therapeutics falls 19.4%
Sorrento Therapeutics is down 19.4%, or $2.07, to $8.61
April 7, 2014
08:52 EDTCEMIChembio Diagnostics terminates U.S. distribution agreement with Alere
Subscribe for More Information
April 4, 2014
08:11 EDTCGIXCancer Genetics launches CALR mutation analysis test
Cancer Genetics has launched a genetic diagnostic test for detecting mutations in the calreticulin gene. This test helps physicians identify patients with certain types of myeloproliferative neoplasms, which are blood cancers that have the potential to evolve into acute leukemia. CGI is one of the first laboratories in the U.S. to offer this test under both CLIA and NY-State Approvals. Patients with the CALR mutation are understood to have more favorable disease outcomes as well as longer overall survival in comparison to patients who possess other biomarkers. Therefore, the results of the test could have implications in predicting a patient's outlook.
06:11 EDTSRNESorrento Therapeutics announces presentation of data from clinical study of RTX
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use